LetterLetter
Hydroxychloroquine and Antimalarials
Luis Caminal-Montero and Silvia Suárez-Díaz
The Journal of Rheumatology July 2019, jrheum.190559; DOI: https://doi.org/10.3899/jrheum.190559
Luis Caminal-Montero
Autoimmune Systemic Diseases Unit, Internal Medicine, Hospital Universitario Central de Asturias, Oviedo, Spain. Address correspondence to L. Caminal-Montero, Autoimmune Diseases Unit, Internal Medicine, Hospital Universitario Central de Asturias, Avda Roma s/n. 33011, Oviedo, Spain. E-mail: lcaminal@yahoo.es
Silvia Suárez-Díaz
Autoimmune Systemic Diseases Unit, Internal Medicine, Hospital Universitario Central de Asturias, Oviedo, Spain. Address correspondence to L. Caminal-Montero, Autoimmune Diseases Unit, Internal Medicine, Hospital Universitario Central de Asturias, Avda Roma s/n. 33011, Oviedo, Spain. E-mail: lcaminal@yahoo.es
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Hydroxychloroquine and Antimalarials
Luis Caminal-Montero, Silvia Suárez-Díaz
The Journal of Rheumatology Jul 2019, jrheum.190559; DOI: 10.3899/jrheum.190559